Doctrine page

Cloning and Human Embryonic Material

Are processes for cloning, germ line modification or the use of human embryos patentable?

Processes for cloning human beings and animals and for modifying the germ line are non-patentable subject matter under section 3(b), as being contrary to public order or morality.

Doctrine last updated on 19 November 2026

Cite this page

Cloning and Human Embryonic Material, Ali on Patents, www.aop.onl/cloning-and-embryos

1Section 3(b) bars the Patent Office from granting patents for inventions whose primary or intended use or commercial exploitation is contrary to public order or morality, or causes serious prejudice to human, animal or plant life or health, or to the environment (Patents Act 1970, s 3(b)). The Biotechnology Examination Guidelines of 2013 identifies processes for cloning human beings and animals as well as processes for modifying the germ line of human beings, as non-patentable subject matter. (Guidelines for Examination of Biotechnology Applications for Patent 2013, para 10(a)–(b)). The Draft Biotechnology Examination Guidelines of 2026 also reiterates this position, where section 3(b) exclusions are illustrated through human embryo destruction for stem-cell derivation and germline editing of human embryos. (Draft Guidelines for Examination of Biotechnology Applications for Patent 2026).

Provisions and topics

Provisions
Topics

See also

Doctrine page

Plants, Animals and Seeds

Are plants, animals and seeds patentable in India?

Doctrine page

Public Order and Morality

Can an invention be refused a patent in India because it is dangerous or immoral?

Doctrine page · Written by Prof. Feroz Ali

www.aop.onl/cloning-and-embryos